PRESS RELEASE
Collaborations designed to influence the pace of change in the PF Community
CHICAGO, August 29, 2022 — To underscore its role as a change agent for all patients and families affected by interstitial lung diseases such as pulmonary fibrosis (PF), Three Lakes Foundation has joined industry sponsors in Boston on August 30 through September 1 in supporting the sixth annual IPF Summit. The summit brought together members of the PF Community to connect and discuss how to overcome the current challenges of advancing research and therapeutics for three million patients suffering with PF worldwide.
During the conference, Three Lakes Foundation hosted a special event entitled “Accelerating Innovation” to share the collaborations that focused on improving diagnosis and accelerating therapies. The event brought together pioneers from academia and industry to discuss the pace of innovation and address the problems of diagnosis delays and new therapies for PF/IPF.
“This gathering of healthcare leaders reinforces our joint commitment to come together, share challenges and contribute to solutions to help patients today, while we work on tomorrow’s transformative medicines,” said Dana Ball, executive director of Three Lakes Foundation. “We are proud to share these exciting projects. We are at the cusp of new discoveries in early diagnoses and therapeutic options.”
The evening highlights included:
Rich Schuch, Chief Learning Officer & SVP, Education. American College of Chest Physicians (CHEST). Schuch will provide a brief summary of their collaboration to inform and educate primary care physicians — “CHEST: Bridging SpecialtiesTM: Timely Diagnosis for ILD patients.” For more information, click here.
Lee Gazourian, MD, Lahey Hospital & Medical Center. Dr. Gazourian presents his insights on how to utilize AI-powered imaging technology for diagnoses — “Advanced Technologies to screen and diagnose early UIP/ILA.”
Naftali Kaminski, MD, Chief of Yale Medicine Pulmonary, Critical Care and Sleep Medicine. Dr. Kaminski will discuss “Beyond IPF Cell Atlas: Introducing the IPF Connectome.” For more information, click here.
Matt Wilson, MD, CEO of uMed. Dr. Wilson will share his excitement about the creation of a global ILD/PF cohort. “A Global Platform for Cohort Development and Generation of Prospective, Real-World Evidence.” Click here to visit their website.
The 2022 IPF Summit united 150 industry giants, pioneering academics, and organizations across autoimmunity, regenerative medicine and inflammation categories who are turning toward PF/IPF as a strategic opportunity. This was the first live event held since 2019.
About Three Lakes Foundation Three Lakes Foundation (TLF) is a nonprofit dedicated to serving as a catalyst for uniting research, industries, and philanthropy in pulmonary fibrosis. We connect entrepreneurs, advocates and institutions to an innovation ecosystem that will transform our approach to improve time to diagnosis and accelerate new therapies. To learn more, visit threelakesfoundation.org.
